Avigen to host conference call Wednesday, October 24, at 1:30 p.m. EDT
ALAMEDA, Calif., Oct. 17 /PRNewswire-FirstCall/ -- Avigen, Inc. (Nasdaq: AVGN), a biopharmaceutical company developing innovative therapies for the treatment of neurological conditions, will hold its quarterly conference call to discuss third quarter results on Wednesday, October 24, 2007, at 1:30 p.m. EDT (10:30 a.m. PDT). Kenneth Chahine, Chief Executive Officer, and Michael Coffee, Chief Business Officer, can be heard by calling 888-396-2369 (U.S.) or 617-847-8710 (non-U.S. locations) using passcode 85761637.
This call is being webcast by Thomson/CCBN and can be accessed at Avigen's website at http://www.avigen.com. The webcast is also being distributed through the Thomson StreetEvents Network. Individual investors can listen to the call at http://www.earnings.com, Thomson's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson StreetEvents (http://www.streetevents.com), a password-protected event management site.
A rebroadcast of the call will be available shortly after the conclusion of the session. The replay may be accessed over the Internet at http://www.avigen.com or by calling 888-286-8010 (U.S.) or 617-801-6888 (non-U.S. locations) using passcode 67087442.
Avigen, Inc. is a biopharmaceutical company focused on unique small
molecule therapeutics and biologics to treat serious, chronic neurological
disorders, including neuropathic pain and
|SOURCE Avigen, Inc.|
Copyright©2007 PR Newswire.
All rights reserved